A BioRxiv Medical Journal Article Has Been Published Today On Nucana "A Phosphoramidate Modification Of FUDR, NUC-3373, Causes DNA Damage And DAMPs Release From Colorectal Cancer Cells, Potentiating Lymphocyte-Induced Cell Death"

BenzingaOct 11 12:23 ET

NuCana Plc Enhances Offering to $5.4 Million

TipRanksOct 1 06:29 ET

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT NewswiresSep 26 11:07 ET

Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket

BenzingaSep 26 06:31 ET

Trending Stocks Today | TELESIS BIO Shoots up 124.13% Post-Market

Moomoo NewsSep 25 17:10 ET

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

GlobeNewswireSep 25 16:01 ET